HOLOGIC INC (HOLX) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, HOLOGIC INC's filing signal continuing negative.

Hologic, Inc. is a global developer, manufacturer, and supplier of diagnostics, medical imaging, and surgical products focused on women's health. The company operates across four key segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Its Diagnostics segment offers molecular diagnostic assays, cytology systems, and rapid tests, notably the Aptima assays for sexually transmitted diseases and the ThinPrep system for cervical cancer screening. The Breast Health segment provides mammography systems, biopsy guidance, and surgical solutions, while GYN Surgical offers hysteroscopic tissue removal and endometrial ablation systems. Skeletal Health includes bone densitometry and mini C-arm imaging systems. Hologic sells its products through direct sales and service personnel, as well as a network of distributors.

Revenue is driven by the sale of diagnostic assays and instrumentation, mammography and biopsy systems, GYN surgical devices, and skeletal health products. Service and other revenues, primarily from field service and maintenance contracts, also contribute to overall revenue.